Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Marsh & Mclennan Companies (MRSH) Cost of Revenue (2016 - 2026)

Marsh & Mclennan Companies filings provide 18 years of Cost of Revenue readings, the most recent being $1.7 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 42.04% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.7 billion, a 19.17% increase, with the full-year FY2025 number at $5.2 billion, up 11.54% from a year prior.
  • Cost of Revenue reached $1.7 billion in Q1 2026 per MRSH's latest filing, up from $1.4 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $1.7 billion in Q1 2026, with the low at $991.0 million in Q1 2023.
  • A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 define the central range for Cost of Revenue.
  • Year-over-year, Cost of Revenue decreased 9.28% in 2023 and then surged 42.04% in 2026.
  • Year by year, Cost of Revenue stood at $1.3 billion in 2022, then decreased by 9.28% to $1.2 billion in 2023, then grew by 9.47% to $1.3 billion in 2024, then rose by 11.04% to $1.4 billion in 2025, then increased by 19.12% to $1.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRSH's Cost of Revenue are $1.7 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025).